Sara Mariotto

Neurologist
AOUI Verona
Verona | Italy

Sara Mariotto (MD, PhD) is a Neurologist who works at the AOUI Verona, Italy where she is responsible for the diagnosis of NMOSD, MOGAD and autoimmune encephalitis and is the referring clinical consultant for neuroimmunological disorders. She graduated in Medicine and Surgery in 2010 and specialised in neurology in 2016 at the University of Verona, Italy. She then completed a 3-year PhD at the Department of Neurosciences, Biomedicine, and Movement Sciences, University of Verona, Italy in 2020 also obtaining the certificate of Doctor Europaeus. After her PhD she was awarded an 8-month scholarship on the study of diagnostic and prognostic test in antibody-mediated encephalitis and neuromyelitis optica.

Her principal field of interest is the study of autoimmune/inflammatory encephalitis, encephalomyelitis, NMOSD, MOGAD, and novel diagnostic/prognostic biomarkers. In relation to these topics, she studied antibody-mediated CNS disorders during her fellowship at the Clinical Department of Neurology, Medical University of Innsbruck and at the Institute of Neurology, Medical University of Vienna (March-October 2017).

She actively participates to the clinical and research activities, collaborative study design, and discussion of challenging national cases with CNS inflammatory and autoimmune conditions.

Her research recently focused on increasing the diagnostic sensitivity for NMOSD and MOGAD and the analysis of novel biomarkers of disease activity in different neurological conditional including also movement and functional neurological disorders.

Dr. Mariotto has more than 120 peer-reviewed research articles/reviews (19 of which focused on neurofilament light chain values in different neurological conditions), she was invited to perform 100 platform presentations, presented 14 posters at national and international meetings and organised 10 international congresses. She is also member of the editorial boards of international journals and the associated editor of Immunologic Research. Finally, she is part of the International clinical consortium for the study of NMOSD, of the Neuroimmunology Board of the European Academy of Neurology, of the Scientific Panel of the Sumaira Foundation, of the EAN/ECTRIMS task force for the guideline on treatment in NMOSD, and of the EAN task force for Autoimmune Encephalitis guidelines. In 2022 she was awarded for “Bando Ricerca Finalizzata 2021”, as a Young Researcher on a project entitled “Multiparametric biomarkers to predict the response to different protocols of motor-cognitive rehabilitation in Parkinson’s disease subjects with postural instability and gait disorders” and for a Spark Grant of the TSF for a project entitled “Myelin basic Protein as a potential biomarker in MOGAD”.

H index (Scopus): 28.